 | • レポートコード：MRC2-11QY03265 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は双極性障害治療薬のグローバル市場について調査・分析したレポートです。種類別（気分安定薬、抗精神病薬、抗うつ薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別双極性障害治療薬の競争状況、市場シェア ・世界の双極性障害治療薬市場：種類別市場規模 2015年-2020年（気分安定薬、抗精神病薬、抗うつ薬、その他） ・世界の双極性障害治療薬市場：種類別市場規模予測 2021年-2026年（気分安定薬、抗精神病薬、抗うつ薬、その他） ・世界の双極性障害治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の双極性障害治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の双極性障害治療薬市場分析：米国、カナダ ・ヨーロッパの双極性障害治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの双極性障害治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の双極性障害治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの双極性障害治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、AstraZeneca、Eli Lilly、GlaxoSmithKline、Janssen Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics.
Rise in prevalence of bipolar disorder, high unmet medical needs, technological advancement and government initiatives are the key factors accelerating the growth of the bipolar disorder therapeutics market. Increase in investment in research and development and collaboration activities between companies for product development are the other factors likely to propel the bipolar disorder therapeutics market. Additionally, the rise in awareness about the disorder has led to increased understanding among the public. This has led to a rise in the number of individuals seeking medical attention for the treatment of the disorder. Also, strategic alliances formed between vendors help in increased penetration of the drugs in the market and increase market share. However, stringent regulations act as a major restraint of the bipolar disorder therapeutics market. North America dominates the global bipolar disorder therapeutics market due to new product innovation, increased awareness among people about bipolar disease, and rise in prevalence of bipolar disorders.
Market Analysis and Insights: Global Biopolar Disorder Therapeutics Market
The global Biopolar Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biopolar Disorder Therapeutics Scope and Market Size
Biopolar Disorder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopolar Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biopolar Disorder Therapeutics market is segmented into
Mood Stabilizers
Antipsychotic Drugs
Antidepressant Drugs
Others
Segment by Application, the Biopolar Disorder Therapeutics market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Biopolar Disorder Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biopolar Disorder Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biopolar Disorder Therapeutics Market Share Analysis
Biopolar Disorder Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biopolar Disorder Therapeutics business, the date to enter into the Biopolar Disorder Therapeutics market, Biopolar Disorder Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Allergan
AstraZeneca
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
…
1 Study Coverage
1.1 Biopolar Disorder Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Biopolar Disorder Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biopolar Disorder Therapeutics Market Size Growth Rate by Type
1.4.2 Mood Stabilizers
1.4.3 Antipsychotic Drugs
1.4.4 Antidepressant Drugs
1.4.5 Others
1.5 Market by Application
1.5.1 Global Biopolar Disorder Therapeutics Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biopolar Disorder Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Biopolar Disorder Therapeutics Revenue 2015-2026
2.1.2 Global Biopolar Disorder Therapeutics Sales 2015-2026
2.2 Global Biopolar Disorder Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biopolar Disorder Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biopolar Disorder Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biopolar Disorder Therapeutics Competitor Landscape by Players
3.1 Biopolar Disorder Therapeutics Sales by Manufacturers
3.1.1 Biopolar Disorder Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Biopolar Disorder Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Biopolar Disorder Therapeutics Revenue by Manufacturers
3.2.1 Biopolar Disorder Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Biopolar Disorder Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biopolar Disorder Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biopolar Disorder Therapeutics Revenue in 2019
3.2.5 Global Biopolar Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biopolar Disorder Therapeutics Price by Manufacturers
3.4 Biopolar Disorder Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Biopolar Disorder Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biopolar Disorder Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Biopolar Disorder Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biopolar Disorder Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Biopolar Disorder Therapeutics Sales by Type (2015-2020)
4.1.2 Global Biopolar Disorder Therapeutics Revenue by Type (2015-2020)
4.1.3 Biopolar Disorder Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biopolar Disorder Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Biopolar Disorder Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Biopolar Disorder Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Biopolar Disorder Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biopolar Disorder Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biopolar Disorder Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Biopolar Disorder Therapeutics Sales by Application (2015-2020)
5.1.2 Global Biopolar Disorder Therapeutics Revenue by Application (2015-2020)
5.1.3 Biopolar Disorder Therapeutics Price by Application (2015-2020)
5.2 Biopolar Disorder Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Biopolar Disorder Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Biopolar Disorder Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Biopolar Disorder Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biopolar Disorder Therapeutics by Country
6.1.1 North America Biopolar Disorder Therapeutics Sales by Country
6.1.2 North America Biopolar Disorder Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biopolar Disorder Therapeutics Market Facts & Figures by Type
6.3 North America Biopolar Disorder Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Biopolar Disorder Therapeutics by Country
7.1.1 Europe Biopolar Disorder Therapeutics Sales by Country
7.1.2 Europe Biopolar Disorder Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biopolar Disorder Therapeutics Market Facts & Figures by Type
7.3 Europe Biopolar Disorder Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biopolar Disorder Therapeutics by Region
8.1.1 Asia Pacific Biopolar Disorder Therapeutics Sales by Region
8.1.2 Asia Pacific Biopolar Disorder Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biopolar Disorder Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Biopolar Disorder Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biopolar Disorder Therapeutics by Country
9.1.1 Latin America Biopolar Disorder Therapeutics Sales by Country
9.1.2 Latin America Biopolar Disorder Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biopolar Disorder Therapeutics Market Facts & Figures by Type
9.3 Central & South America Biopolar Disorder Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biopolar Disorder Therapeutics by Country
10.1.1 Middle East and Africa Biopolar Disorder Therapeutics Sales by Country
10.1.2 Middle East and Africa Biopolar Disorder Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biopolar Disorder Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Biopolar Disorder Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Biopolar Disorder Therapeutics Products Offered
11.1.5 Allergan Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Biopolar Disorder Therapeutics Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description and Business Overview
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Biopolar Disorder Therapeutics Products Offered
11.3.5 Eli Lilly Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Biopolar Disorder Therapeutics Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Corporation Information
11.5.2 Janssen Pharmaceuticals Description and Business Overview
11.5.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Janssen Pharmaceuticals Biopolar Disorder Therapeutics Products Offered
11.5.5 Janssen Pharmaceuticals Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Biopolar Disorder Therapeutics Products Offered
11.1.5 Allergan Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biopolar Disorder Therapeutics Market Estimates and Projections by Region
12.1.1 Global Biopolar Disorder Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Biopolar Disorder Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Biopolar Disorder Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Biopolar Disorder Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Biopolar Disorder Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Biopolar Disorder Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Biopolar Disorder Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Biopolar Disorder Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Biopolar Disorder Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Biopolar Disorder Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biopolar Disorder Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biopolar Disorder Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biopolar Disorder Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biopolar Disorder Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Biopolar Disorder Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Biopolar Disorder Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Biopolar Disorder Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Biopolar Disorder Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biopolar Disorder Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biopolar Disorder Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biopolar Disorder Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biopolar Disorder Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biopolar Disorder Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biopolar Disorder Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Biopolar Disorder Therapeutics Market Segments
Table 2. Ranking of Global Top Biopolar Disorder Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biopolar Disorder Therapeutics Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Mood Stabilizers
Table 5. Major Manufacturers of Antipsychotic Drugs
Table 6. Major Manufacturers of Antidepressant Drugs
Table 7. Major Manufacturers of Others
Table 8. Global Biopolar Disorder Therapeutics Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Biopolar Disorder Therapeutics Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Biopolar Disorder Therapeutics Sales by Regions 2015-2020 (K MT)
Table 11. Global Biopolar Disorder Therapeutics Sales Market Share by Regions (2015-2020)
Table 12. Global Biopolar Disorder Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Biopolar Disorder Therapeutics Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Biopolar Disorder Therapeutics Sales Share by Manufacturers (2015-2020)
Table 15. Global Biopolar Disorder Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Biopolar Disorder Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopolar Disorder Therapeutics as of 2019)
Table 17. Biopolar Disorder Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Biopolar Disorder Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Biopolar Disorder Therapeutics Price (2015-2020) (USD/MT)
Table 20. Biopolar Disorder Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Biopolar Disorder Therapeutics Product Type
Table 22. Date of International Manufacturers Enter into Biopolar Disorder Therapeutics Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopolar Disorder Therapeutics Sales by Type (2015-2020) (K MT)
Table 25. Global Biopolar Disorder Therapeutics Sales Share by Type (2015-2020)
Table 26. Global Biopolar Disorder Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Biopolar Disorder Therapeutics Revenue Share by Type (2015-2020)
Table 28. Biopolar Disorder Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Biopolar Disorder Therapeutics Sales by Application (2015-2020) (K MT)
Table 30. Global Biopolar Disorder Therapeutics Sales Share by Application (2015-2020)
Table 31. North America Biopolar Disorder Therapeutics Sales by Country (2015-2020) (K MT)
Table 32. North America Biopolar Disorder Therapeutics Sales Market Share by Country (2015-2020)
Table 33. North America Biopolar Disorder Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Biopolar Disorder Therapeutics Revenue Market Share by Country (2015-2020)
Table 35. North America Biopolar Disorder Therapeutics Sales by Type (2015-2020) (K MT)
Table 36. North America Biopolar Disorder Therapeutics Sales Market Share by Type (2015-2020)
Table 37. North America Biopolar Disorder Therapeutics Sales by Application (2015-2020) (K MT)
Table 38. North America Biopolar Disorder Therapeutics Sales Market Share by Application (2015-2020)
Table 39. Europe Biopolar Disorder Therapeutics Sales by Country (2015-2020) (K MT)
Table 40. Europe Biopolar Disorder Therapeutics Sales Market Share by Country (2015-2020)
Table 41. Europe Biopolar Disorder Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Biopolar Disorder Therapeutics Revenue Market Share by Country (2015-2020)
Table 43. Europe Biopolar Disorder Therapeutics Sales by Type (2015-2020) (K MT)
Table 44. Europe Biopolar Disorder Therapeutics Sales Market Share by Type (2015-2020)
Table 45. Europe Biopolar Disorder Therapeutics Sales by Application (2015-2020) (K MT)
Table 46. Europe Biopolar Disorder Therapeutics Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Biopolar Disorder Therapeutics Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Biopolar Disorder Therapeutics Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Biopolar Disorder Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Biopolar Disorder Therapeutics Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Biopolar Disorder Therapeutics Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Biopolar Disorder Therapeutics Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Biopolar Disorder Therapeutics Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Biopolar Disorder Therapeutics Sales Market Share by Application (2015-2020)
Table 55. Latin America Biopolar Disorder Therapeutics Sales by Country (2015-2020) (K MT)
Table 56. Latin America Biopolar Disorder Therapeutics Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Biopolar Disorder Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Biopolar Disorder Therapeutics Revenue Market Share by Country (2015-2020)
Table 59. Latin America Biopolar Disorder Therapeutics Sales by Type (2015-2020) (K MT)
Table 60. Latin America Biopolar Disorder Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Latin America Biopolar Disorder Therapeutics Sales by Application (2015-2020) (K MT)
Table 62. Latin America Biopolar Disorder Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Biopolar Disorder Therapeutics Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Biopolar Disorder Therapeutics Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Biopolar Disorder Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Biopolar Disorder Therapeutics Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Biopolar Disorder Therapeutics Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Biopolar Disorder Therapeutics Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Biopolar Disorder Therapeutics Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Biopolar Disorder Therapeutics Sales Market Share by Application (2015-2020)
Table 71. Allergan Corporation Information
Table 72. Allergan Description and Major Businesses
Table 73. Allergan Biopolar Disorder Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Allergan Product
Table 75. Allergan Recent Development
Table 76. AstraZeneca Corporation Information
Table 77. AstraZeneca Description and Major Businesses
Table 78. AstraZeneca Biopolar Disorder Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. AstraZeneca Product
Table 80. AstraZeneca Recent Development
Table 81. Eli Lilly Corporation Information
Table 82. Eli Lilly Description and Major Businesses
Table 83. Eli Lilly Biopolar Disorder Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Eli Lilly Product
Table 85. Eli Lilly Recent Development
Table 86. GlaxoSmithKline Corporation Information
Table 87. GlaxoSmithKline Description and Major Businesses
Table 88. GlaxoSmithKline Biopolar Disorder Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Recent Development
Table 91. Janssen Pharmaceuticals Corporation Information
Table 92. Janssen Pharmaceuticals Description and Major Businesses
Table 93. Janssen Pharmaceuticals Biopolar Disorder Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Janssen Pharmaceuticals Product
Table 95. Janssen Pharmaceuticals Recent Development
Table 96. Global Biopolar Disorder Therapeutics Sales Forecast by Regions (2021-2026) (K MT)
Table 97. Global Biopolar Disorder Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Biopolar Disorder Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Biopolar Disorder Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Biopolar Disorder Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 101. North America: Biopolar Disorder Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Biopolar Disorder Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 103. Europe: Biopolar Disorder Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Biopolar Disorder Therapeutics Sales Forecast by Region (2021-2026) (K MT)
Table 105. Asia Pacific: Biopolar Disorder Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Biopolar Disorder Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 107. Latin America: Biopolar Disorder Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Biopolar Disorder Therapeutics Sales Forecast by Country (2021-2026) (K MT)
Table 109. Middle East and Africa: Biopolar Disorder Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Biopolar Disorder Therapeutics Players
Table 114. Biopolar Disorder Therapeutics Customers List
Table 115. Biopolar Disorder Therapeutics Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopolar Disorder Therapeutics Product Picture
Figure 2. Global Biopolar Disorder Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Mood Stabilizers Product Picture
Figure 4. Antipsychotic Drugs Product Picture
Figure 5. Antidepressant Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biopolar Disorder Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Biopolar Disorder Therapeutics Report Years Considered
Figure 12. Global Biopolar Disorder Therapeutics Market Size 2015-2026 (US$ Million)
Figure 13. Global Biopolar Disorder Therapeutics Sales 2015-2026 (K MT)
Figure 14. Global Biopolar Disorder Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Biopolar Disorder Therapeutics Sales Market Share by Region (2015-2020)
Figure 16. Global Biopolar Disorder Therapeutics Sales Market Share by Region in 2019
Figure 17. Global Biopolar Disorder Therapeutics Revenue Market Share by Region (2015-2020)
Figure 18. Global Biopolar Disorder Therapeutics Revenue Market Share by Region in 2019
Figure 19. Global Biopolar Disorder Therapeutics Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Biopolar Disorder Therapeutics Revenue in 2019
Figure 21. Biopolar Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Biopolar Disorder Therapeutics Sales Market Share by Type (2015-2020)
Figure 23. Global Biopolar Disorder Therapeutics Sales Market Share by Type in 2019
Figure 24. Global Biopolar Disorder Therapeutics Revenue Market Share by Type (2015-2020)
Figure 25. Global Biopolar Disorder Therapeutics Revenue Market Share by Type in 2019
Figure 26. Global Biopolar Disorder Therapeutics Market Share by Price Range (2015-2020)
Figure 27. Global Biopolar Disorder Therapeutics Sales Market Share by Application (2015-2020)
Figure 28. Global Biopolar Disorder Therapeutics Sales Market Share by Application in 2019
Figure 29. Global Biopolar Disorder Therapeutics Revenue Market Share by Application (2015-2020)
Figure 30. Global Biopolar Disorder Therapeutics Revenue Market Share by Application in 2019
Figure 31. North America Biopolar Disorder Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Biopolar Disorder Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Biopolar Disorder Therapeutics Sales Market Share by Country in 2019
Figure 34. North America Biopolar Disorder Therapeutics Revenue Market Share by Country in 2019
Figure 35. U.S. Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Biopolar Disorder Therapeutics Market Share by Type in 2019
Figure 40. North America Biopolar Disorder Therapeutics Market Share by Application in 2019
Figure 41. Europe Biopolar Disorder Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Biopolar Disorder Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Biopolar Disorder Therapeutics Sales Market Share by Country in 2019
Figure 44. Europe Biopolar Disorder Therapeutics Revenue Market Share by Country in 2019
Figure 45. Germany Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Biopolar Disorder Therapeutics Market Share by Type in 2019
Figure 56. Europe Biopolar Disorder Therapeutics Market Share by Application in 2019
Figure 57. Asia Pacific Biopolar Disorder Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Biopolar Disorder Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Biopolar Disorder Therapeutics Sales Market Share by Region in 2019
Figure 60. Asia Pacific Biopolar Disorder Therapeutics Revenue Market Share by Region in 2019
Figure 61. China Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Biopolar Disorder Therapeutics Market Share by Type in 2019
Figure 84. Asia Pacific Biopolar Disorder Therapeutics Market Share by Application in 2019
Figure 85. Latin America Biopolar Disorder Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Biopolar Disorder Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Biopolar Disorder Therapeutics Sales Market Share by Country in 2019
Figure 88. Latin America Biopolar Disorder Therapeutics Revenue Market Share by Country in 2019
Figure 89. Mexico Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Biopolar Disorder Therapeutics Market Share by Type in 2019
Figure 96. Latin America Biopolar Disorder Therapeutics Market Share by Application in 2019
Figure 97. Middle East and Africa Biopolar Disorder Therapeutics Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Biopolar Disorder Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Biopolar Disorder Therapeutics Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Biopolar Disorder Therapeutics Revenue Market Share by Country in 2019
Figure 101. Turkey Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Biopolar Disorder Therapeutics Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Biopolar Disorder Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Biopolar Disorder Therapeutics Market Share by Type in 2019
Figure 108. Middle East and Africa Biopolar Disorder Therapeutics Market Share by Application in 2019
Figure 109. North America Biopolar Disorder Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Biopolar Disorder Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Biopolar Disorder Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Biopolar Disorder Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Biopolar Disorder Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Biopolar Disorder Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Biopolar Disorder Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Biopolar Disorder Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Biopolar Disorder Therapeutics Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Biopolar Disorder Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …- 心的外傷後ストレス障害（PTSD）治療薬の世界市場（～2026年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…
- 注意欠陥・多動性障害（ADHD）治療薬の世界市場（～2026年） ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. G…
- 女性用性的欲求低下障害（HSDD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Female …
- 強迫性障害治療の世界市場（～2026年） Market Analysis and Insights: Global Obsessive-Compulsive Disorder Treatment Market The global Obsessive-Compulsive Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Obsessive-Compulsive Disorder Treat…